B-cell reconstitution and xenoreactive anti-pig natural, antibody production in severe combined immunodeficient mice reconstituted with immunocompetent B cells from varying sources

Transplantation

Volumn 66, Issue 1, 1998, Pages 89-95

  Yang, Yong Guang ^a   DeGoma, Emil ^a   Barth, Rolf ^a   Sergio, Justin J ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; COMBINED IMMUNODEFICIENCY; GRAFT REJECTION; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, HETEROPHILE; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED BALB C; MICE, SCID; PERITONEUM; SPLEEN; SWINE;

EID: 0032528088     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807150-00014     Document Type: Article

References (53)

1. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
2. Platt JL, Lindman BJ, Geller RL, et al. The role of natural antibodies in the activation of xenogeneic endothelial cells. Transplantation 1991; 52: 1037.
3. Geller RL, Bach FH, Turman MA, Casali P, Platt JL. Evidence that polyreactive antibodies are deposited in rejected discordant xenografts. Transplantation 1993; 55: 168.
4. Vanhove B, Bach FH. Human xenoreactive natural antibodies: avidity and targets on porcine endothelial cells. Transplantation 1993; 56: 1251.
5. McKenzie FC, Vaughan HA, Sandrin MS. How important are anti-Gala(1,3)Gal antibodies in pig-to-human xenotransplantation? Xeno 1994; 2: 107.
6. Blanchard D, Thibaudeau K, Soulillou J- P. Porcine antigenic targets for human natural antibodies. Xeno 1995; 3: 68.
7. Pruitt SK, Baldwin WM III, Barth RN, Sanfilippo F. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts. Transplantation 1993; 56: 1318.
8. Soares MP, Latinne D, Elsen M, Figueroa J, Bach FH, Bazin H. In vivo depletion of xenoreactive natural antibodies with an anti-μ monoclonal antibody. Transplantation 1993; 56: 1427.
9. Watier H, Guillaumin J, Piller F, et al. Removal of terminal α-galactosyl residues from xenogeneic porcine endothelial cells. Transplantation 1996; 62: 105.
10. Sykes M, Lee LA, Sachs DH. Xenograft tolerance. Immunol Rev 1994; 141: 245.
11. Magee JC, Collins BH, Harland RC, Bollinger RR, Frank MM, Platt JL. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. Transplant Proc 1995; 27: 271.
12. Yang Y-G, deGoma E, Ohdan H, et al. Tolerization of anti-gala 1-3 gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998; 187: 1335.
13. Sykes M, Zhao Y, Yang Y-G. Tolerance induction for xenotransplantation. World J Serg 1997; 21: 932.
14. Murakami M, Honjo T. Involvement of B-1 cells in mucosal immunity and autoimmunity. Immunol Today 1995; 16: 534.
15. Xu H, Edwards NM, Chen JM, Kwiatkowski P, Rosenberg SE, Michler RE. Newborn baboon serum lacks natural anti-pig xenoantibody. Transplantation 1995; 59: 1189.
16. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR. The LY-1 B cell lineage. Immunol Rev 1986; 93: 81.
17. Kantor AB, Stall AM, Adams S, Herzenberg LA. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci USA 1992; 89: 3320.
18. Godin IE, Garcia-Porrero JA, Coutinho A, Dieterien-Livre F, Marcos MAR. Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature 1993; 364: 67.
19. Hardy RR, Carmack CE, Li YS, Hayakawa K. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol Rev 1994; 137: 91.
20. Tarlinton D. B-cell differentiation in the bone marrow and the periphery. Immunol Rev 1994; 137: 203.
21. Iacomini J, Imanishi-Kari T. The effect of an immunoglobulin mu transgene on B cell maturation. Eur J Immunol 1992; 22: 745.
22. + B cells. Eur J Immunol 1996; 26: 2537.
23. Murakami M, Honjo T. Involvement of B-1 cells in mucosal immunity and autoimmunity. Immunol Today 1995; 16: 534.
24. Murakami M, Tsubata T, Okamoto M, et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992; 357: 77.
25. Mantovani L, Wilder RL, Casali P. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol 1993; 151: 473.
26. Murakami M, Nakajima K, Yamazaki K, Muraguchi T, Serikawa T, Honjo T. Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgeneic mice. J Exp Med 1997; 185: 791.
27. Galili U. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol 1993; 15: 155.
28. Auchincloss HJ. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
29. Kaplon RJ, Michler RE, Hu X, Kwiatkowski PA, Edwards NM, Platt JL. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation 1995; 59: 1.
30. Sachs DH. MHC-homozygous miniature swine. In: Swindle MM, Moody DC, Phillips LD, eds. Swine as models in biomedical research. Ames, IA: Iowa State University Press, 1992: 3.
31. Pennington LR, Sakamoto K, Popitz-Bergez F, et al. Bone marrow transplantation in miniature swine. I. Development of the model. Transplantation 1988; 45: 21.
32. Gritsch HA, Glaser RM, Emery DW, et al. The importance of non-immune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation 1994; 57: 906.
33. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to human Leu3/T4 molecule. J Immunol 1983; 131: 2445.
34. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 1980; 125: 2665.
35. Sykes M, Abraham VS, Harty MW, Pearson DA. IL-2 reduces graft-vs-host disease and preserves a graft-vs-leukemia effect by selectively inhibiting CD4+ T cell activity. J Immunol 1993; 150: 197.
36. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994; 83: 939.
37. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150: 580.
38. Bosma GC, Fried M, Custer RP, Carroll A, Gibson DM, Bosma MJ. Evidence of functional lymphocytes in some (LEAKY) seid mice. J Exp Med 1988; 1016.
39. Carroll AM, Hardy RR, Bosma MJ. Occurrence of mature B (IgM+, B220+) and T (CD3+) lymphocytes in SCID mice. J Immunol 1989; 143: 1087.
40. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol 1993; 11: 501.
41. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995; 376: 352.
42. Engel P, Zhou L-J, Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995; 3: 39.
43. Zang R, Ait FW, Davidson L, Orkin SH, Swat W. Defective signaling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 1995; 374: 470.
44. Tarakhovsky A, Turner M, Schaal S, et al. Deflective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995; 374: 467.
45. Yoshida T, Ikuta K, Sugaya H, et al. Defective B-1 cell development and impaired immunity against angiostrongylus cantonensis in IL-5Rα-deficient mice. Immunity 1996; 4: 483.
46. Kopf M, Brombacher F, Hodgkin PD, et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996; 4: 15.
47. Vaux DL, Lalor PA, Cory S, Johnson GR. In vivo expression of interleukin 5 induces an eosinophilia and expanded Ly-1B lineage populations. Int Immunol 1990; 2: 965.
48. Riggs JE, Stowers RS, Mosier DE. The immunoglobulin allotype contributed by peritoneal cavity B cells dominates in SCID mice reconstituted with allotype-disparate mixtures of splenic and peritoneal cavity B cells. J Exp Med 1990; 172: 475.
49. Wortis HH, Teutsch M, Higer M, Zheng J, Parker DC. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative pathways and results in different B-cell phenotypes. Proc Natl Acad Sci USA 1995; 92: 3348.
50. Arnold LW, Pennel CA, McCray SK, Clarke SH. Development of B-1 cells: segregation of phosphatidy choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med 1994; 179: 1585.
51. Osmond DG. Population dynamics of bone marrow B lymphocytes. Immunol Rev 1986; 93: 103.
52. Parker W, Yu PB, Holzknecht ZE, Lundberg K, Buckley RH, Platt JL. Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development. J Clin Immunol 1997; 17: 311.
53. Latinne D, Vitiello D, Sachs DH, Sykes M. Tolerance to discordant xenografts: I. Human natural antibody determinants are shared on miniature swine bone marrow cells and endothelial cells. Transplantation 1994; 57: 238.